CSAM Health Group AS

CSAM Health Group AS provides various ehealth solutions in Norway and internationally. The company offers CSAM Arcidis, an integrated system for teleradiology; CSAM DICOM Server for handling radiology data; CSAM HelseMail for transfer of confidential patient data between healthcare organizations; CSAM Infobroker, a vendor-neutral telemedicine system for radiology that enables multiple clinicians to share resources and knowledge; CSAM S7, a platform for self-care and health counselling; CSAM Web Client, a web-based user interface and connectivity solution that allows users to access multiple CSAM applications and functions; and CSAM XDS, a central archive for storing and managing various types of clinical patient data. It also provides CSAM Cardio, an ECG and diagnostic storage tool; CSAM CIMA, a mobile application for capturing, using, and sending medical media; CSAM Media, a web-based medical imaging solution; CSAM Medimaker for image management and workflow solution; CSAM Picsara, an image management solution; and CSAM TRIS, a radiology information system. In addition, the company offers CSAM Partus, a maternity information system; CSAM Natus, a maternity care system; CSAM iPana Labor Information System, a web-based labour information system; CSAM iPana Maternity, a cloud-based service platform that enables expectant mothers, hospitals, and maternity clinics to electronically collect, store, and share medical information; and CSAM Fertsoft, a care and practice management software. Further, it provides CSAM Optima Predict solution for operational planning; CSAM Optima Live; CSAM AMIS, an emergency medical information system; CSAM IMTS, a tool for assessing and prioritizing patients; CSAM Paratus, an emergency response system; CSAM CoordCom; CSAM ResQMobile; CSAM Cytodose, an oncology management solution; and CSAM ProSang, an advanced laboratory information management system. The company was founded in 1999 and is headquartered in Oslo, Norway.

CSAM Health Group AS trades as CSAMF on OTC. The company is classified in Healthcare / Medical - Healthcare Information Services and reports in USD.

The current profile places the business in Medical - Healthcare Information Services. This section is intended to summarize the operating segments, products, geographies, and main revenue lines from official filings.

Latest available fiscal data shows $424.96M of revenue and -$59.29M of net income.

Use this area for management strategy, capital allocation priorities, target markets, and measurable goals from the latest annual report or investor presentation.

The app now provides the structure, but exact strategic claims should come from official company documents before being treated as a finished investment thesis.

CSAM Health Group AS can be compared against peers such as Adocia S.A., Carmat S.A., BioHarvest Sciences Inc., China Medical & HealthCare Group Limited, Eupraxia Pharmaceuticals Inc., Healthcare Integrated Technologies, Inc..

A complete thesis should compare growth, margins, balance-sheet risk, valuation multiples, and market position against direct competitors.

Current signals to investigate include market capitalization of $98.80M, beta of 0.58, and return on equity of -240.3%.

This section should be validated with evidence such as durable margins, brand strength, regulation, switching costs, cost advantage, distribution, or technology.

Key risks should include financial leverage, cyclicality, customer concentration, regulatory exposure, currency risk, and execution risk.

CSAMF currently shows total debt of $483.17M and beta of 0.58. Missing data should be treated as a research gap, not as low risk.

Production-capacity detail is not available as structured data yet. For industrial, defense, semiconductor, or real-estate companies, this should be reviewed from annual reports and investor presentations.

No structured backlog field is available yet. If the company reports backlog, review the relevant filing section before adding it to the thesis.

Use this section for major contracts, product launches, construction projects, acquisitions, or strategic programs that can materially affect valuation.

No recent SEC-style filings are available for this symbol yet.

Customer concentration is not available as structured data here. Add it from official filings when a company discloses material customers or revenue concentration.

Supplier concentration and critical supply-chain dependencies are not available as structured data here. This should be researched from annual reports and risk disclosures.

Company website: https://www.csamhealth.com

For US-listed stocks, verify the thesis against official filings, earnings call transcripts, and company investor relations materials.